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Chondrogenesisexpressed in osteoblasts and is required for osteoblast differentiation. Mice
overexpressing Wdr5 under the control of the mouse α(1)I collagen promoter (Col I-Wdr5) display
accelerated osteoblast differentiation as well as accelerated chondrocyte differentiation, suggesting that
overexpression of Wdr5 in osteoblasts affects chondrocyte differentiation. To elucidate the molecular
mechanism by which overexpression of Wdr5 in the perichondrium regulates chondrocyte differentiation,
studies were undertaken using skeletal elements and cultured metatarsals isolated from wild-type and
Col I-Wdr5 embryos. FGF18 mRNA levels were decreased in Col I-Wdr5 humeri. Furthermore, local
delivery of FGF18 to the bone collar of ex vivo cultures of metatarsals attenuated the chondrocyte
phenotype of the Col I-Wdr5 metatarsals. Impairing local FGF action in wild-type metatarsals resulted in a
chondrocyte phenotype analogous to that of Col I-Wdr5 metatarsals implicating impaired FGF action as
the cause of the phenotype observed. The expression of Twist-1, which regulates chondrocyte
differentiation, was increased in Col I-Wdr5 humeri. Chromatin immunoprecipitation analyses demon-
strated that Wdr5 is recruited to the Twist-1 promoter. These ﬁndings support a model in which
overexpression of Wdr5 in the perichondrium promotes chondrocyte differentiation by modulating the
expression of Twist-1 and FGF18.
© 2009 Elsevier Inc. All rights reserved.IntroductionEndochondral bone formation is a highly regulated process that
is initiated when mesenchymal cells form condensations and ends
with the formation of a mineralized skeleton. During endochondral
bone formation, mesenchymal cells within the condensations
differentiate into proliferating chondrocytes, which in turn differ-
entiate into hypertrophic chondrocytes and form a cartilage
template. Cells surrounding this cartilage anlagen differentiate into
osteoblasts forming the perichondrium (Karsenty, 1999; Karsenty
and Wagner, 2002; Liu et al., 2007; Liu et al., 2002; Marie, 2003;
Ohbayashi et al., 2002; Olsen et al., 2000; Wagner and Karsenty,
2001). Studies in genetically modiﬁed mice, point to an intricate
network of signals that regulate the proliferation and differentiation
of growth plate chondrocytes, as well as osteoblast differentiation.
Among the local signaling pathways that are known to play a role in
these processes are the canonical Wnt signaling (Akiyama et al.,
2004; Hartmann, 2006; Hartmann and Tabin, 2000; Hu et al., 2005;
Kawakami et al., 2000; Kawakami et al., 1999; Krishnan et al., 2006;
Westendorf et al., 2004; Yamaguchi et al., 1999), bone morphoge-
netic protein (BMP) (Canalis et al., 2003; Ducy and Karsenty, 2000;
Hoffmann and Gross, 2001; Kronenberg, 2003), parathyroid hor-).
l rights reserved.mone related peptide (PTHrP), Indian Hedgehog (Ihh) (Chung et al.,
1998, 2001; Karaplis et al., 1994; Karp et al., 2000; Kobayashi et al.,
2002; Kronenberg, 2003; Lanske et al., 1999; Schipani et al., 1997;
St-Jacques et al., 1999; Vortkamp et al., 1996) and ﬁbroblast growth
factor (FGF) (Colvin et al., 1996; Kronenberg, 2003; Marie, 2003;
Ornitz, 2005; Wang et al., 1999) pathways. Several studies have
demonstrated that the perichondrium regulates cartilage growth, by
providing a source of signaling molecules that regulate chondrocyte
proliferation and differentiation (Di Nino et al., 2001; Gamer et al.,
2008; Hinoi et al., 2006; Long and Linsenmayer, 1998; Marie, 2003;
Ornitz, 2005; Vortkamp et al., 1996).
Wdr5, a BMP-2-induced gene, encodes a protein belonging to the
WD repeat family of β-propeller proteins (Gori et al., 2001). These
proteins are crucial for numerous cellular functions including signal
transduction, mRNA processing, gene regulation and cell cycle
regulation (Neer et al., 1994; Smith et al., 1999; Wysocka et al.,
2003). Wdr5 is a critical component of the Set/Ash histone
methyltransferase complex and is essential for histone H3 lysine 4
(H3K4) trimethylation, a marker associated with transcriptional
activation of genes (Wysocka et al., 2005). The ﬁnding that silencing
of Wdr5 dramatically impairs the expression of several genes
including Runx-2, osteocalcin, Wnt1 and Wnt3a in MC3T3-E1 cells
(Zhu et al., 2008) points to a critical role for Wdr5 in regulating the
expression of genes involved in osteoblast and chondrocyte
differentiation.
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sion of Wdr5 in MC3T3-E1 cells dramatically accelerates the
program of osteoblastic differentiation, whereas suppression of
Wdr5 expression markedly impairs osteoblast differentiation (Gori
et al., 2001, 2006; Zhu et al., 2008). Mice overexpressing Wdr5 in
osteoblasts, under the control of the mouse α(1) I collagen
promoter (Col I-Wdr5), display acceleration of endochondral and
intramembranous bone formation (Gori et al., 2006). At embryonic
day (E) 14.5, the long bones of Col I-Wdr5 embryos are longer than
those isolated from wild-type littermates due to a larger zone of
hypertrophic chondrocytes (Gori et al., 2006), implying that Wdr5
overexpression in the perichondrium affects the expression of
factors that regulate chondrocyte differentiation in a paracrine
manner. Studies were, therefore, undertaken to address the
molecular mechanism by which overexpression of Wdr5 in the
perichondrium inﬂuences chondrocyte differentiation.
Materials and methods
Metatarsal isolation
Hind limbs isolated from E15.5 Col I-Wdr5 embryos and their
wild-type littermates were transferred to a 100 μl drop of medium
for further dissection. Soft tissues were peeled off the tibia and
metatarsals, while holding the femur to stabilize the limb. The
phalangeal rudiments of the three middle digits were removed
along with the soft tissue, permitting the isolation of the middle
three metatarsals. Each metatarsal was then dissected and trans-
ferred to a 24 well plate in 500 μl of medium (high glucose DMEM
with sodium pyruvate and pyridoxine, supplemented with 1%
penicillin/streptomycin, 0.05 mg/ml ascorbic acid and 0.25% heat-
inactivated FBS). After 24 h in culture, the rudiments were removed
to a 100 μl drop of DMEM in a sterile dish under a dissection
microscope. The elements were stabilized with forceps to permit
insertion of a Heparin acrylic bead (Sigma Chemical Co, St. Louis,
MO) or Afﬁgel blue beads (BioRad, Hercules, CA) below the
periosteum of the bone collar (in the middle third of the
metatarsal). Heparin acrylic beads (Sigma Chemical Co, St. Louis,
MO) were incubated with 1 mg/ml of FGF18 (Preprotech, Rocky
Hill, NJ), or 1 mg/ml of BSA for 1 h at room temperature prior to
implantation. To examine the effects of inhibiting the FGF pathway,
Afﬁgel blue beads (BioRad, Hercules, CA) were incubated with
DMSO (Sigma Chemical Co, St. Louis, MO) in saline with or without
10–100 nM of the FGF inhibitor PD173074 (PD2499 Sigma Chemical
Co, St. Louis, MO) (Skaper et al., 2000) for 1 h at room temperature
prior to implantation. The metatarsal explants were then returned
to the culture well and incubated for 4 days, at which time theFig. 1. The Col I-Wdr5 transgene accelerates chondrocyte differentiation. (A) Humeri isolated
type (wt) and Col I-Wdr5 embryos, (C) metatarsals isolated from E15.5 wild-type (wt) an
hypertrophic layer. Representative skeletal elements from at least three wild-type and Col Iexplants were harvested for analyses. Mice were maintained in a
virus and parasite-free barrier facility and exposed to a 12 hour
light/dark cycle. All studies were approved by the institutional
animal care committee.
Histological evaluation
Forelimbs isolated from 14.5 dpc embryos and metatarsals were
ﬁxed in 4% paraformaldehyde. After 24 h the specimens were
transferred to a 5% sucrose solution followed by an overnight
incubation in 30% sucrose. Specimens were then embedded for frozen
sections. Tissue blocks were cut into 5 μm sections for metatarsals and
10 μm for forelimbs and stained with Toluidine Blue or Hematoxylin
and Eosin (H and E) to permit phenotypic analyses.
In situ hybridization analyses
Digoxigenin (DIG-) or 35S-UTP labeled probes were used for in situ
hybridization as previously described (Gori et al., 2006). Twist-1 and
FGF-18 probes used in these studies were kindly provided by Dr. G.
Karsenty (Columbia University, New York, NY) and Dr. D.M. Ornitz
(Washington University, St Louis. MO), respectively.
BrdU incorporation
Pregnant females were injected intra-peritoneally with 100 mg of
BrdU/12 mg of FdU (5-Flouro-2′-deoxyuridine) per g of body weight
at E14.5 and sacriﬁced 1 and 13 h later. Embryonic forelimbs were
then ﬁxed, processed and sectioned using standard procedures. BrdU
positive (BrdU+ve) nuclei were detected using a Zymed immunos-
taining Kit (Zymed, San Francisco, CA) according to the manufac-
turer's instructions. BrdU+ve and BrdU-negative (BrdU−ve) nuclei
were counted in three similarly sized regions of each the round and
ﬂat proliferating areas as well as in the hypertrophic region of
forelimbs isolated from Col I-Wdr5 embryos and their wild-type
littermates. Data were expressed as percent positive nuclei in the
selected areas.
Quantitative real-time RT-PCR
Humeri were isolated from E14.5 Col I-Wdr5 embryos and
their wild-type littermates and dissected free of adjacent tissue
under a dissection microscope. Total RNA was extracted using the
RNeasy Plus Mini Kit (Qiagen, Valencia, CA). cDNA was synthe-
sized using Superscript II reverse transcriptase (Invitrogen,
Carlsbad, CA). Quantitative real-time RT-PCR was performed
using the Opticon DNA Engine System (MJ Research, Waltham,from E14.5 wild-type (wt) and Col I-Wdr5 embryos, (B) Paws isolated from E15.5 wild-
d Col I-Wdr5 embryos and cultured for 4 days. Brackets indicate the expansion of the
-Wdr5 embryos are shown.
Table 1
BrdU incorporation
% BrdU+ cells % BrdU+ cells pulse-chase (13 h)
wt Col I-Wdr5 wt Col I-Wdr5
19.3±1.39 31.4±1.79⁎⁎ Round 11.4±2.34 23.6±4.57⁎
Flat 26.3±3.07 34.54±2.2⁎
Hypertrophic 14.7±2.98 29.9±3.94⁎
BrdU incorporation of chondrocytes in humeri isolated from E14.5 wild-type (wt) and
Col I-Wdr5 embryos. n=7 for BrdU incorporation±S.E.M. and n=3 for pulse-chase
experiments±S.E.M.
⁎ pb0.05 and ⁎⁎ pb0.001 by Student's t-test.
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ized for actin mRNA in the same sample using the formula of
Livak and Schmittgen (2001).
Chromatin immunoprecipitation (ChIP) analyses
MC3T3-E1 cells were plated at a density of 5×103 cells/cm2 and
cultured for 7 days. Chromatin immunoprecipitation was performed as
previously reported (Huebert et al., 2006; Zhuet al., 2008) using 10 μg of
α-Wdr5. Real-time PCR was performed using primers amplifying the
Twist-1 promoter (−580/−400). Primers amplifying sequences in the
Twist-1 coding region were used to normalize for DNA content and to
calculate the enrichment of the promoter sequences relative to control
sequences in the ChIP samples using the formula of Livak and
Schmittgen as previously reported (Livak and Schmittgen, 2001; Zhu
et al., 2008). Twist-1 promoter primers: F 5′-GGTTTCCGACTAGAGGTTT-
3′; R 5′-TGTGACAGCAGTAGTGGC-3′; Twist-1 coding region primers: F
5′-TCGGACAAGCTGAGCAA-3′; R 5′-CGGAGAAGGCGTAGCT-3′.
Statistical analysis
Student's paired t-test was used to evaluate differences between
humeri isolated from wild type and Col I-Wdr5 embryos and in
MC3T3-E1 cells between ChIP samples and input samples. A p value
b0.05 was considered statistically signiﬁcant.Fig. 2.Molecular analyses of chondrocyte differentiation. Sections of humeri and metatarsal
type X collagen (Col X) and osteopontin (OP) antisense riboprobes were digoxigenin (DIG
template. Representative skeletal elements from at least three wild-type (wt) and Col I-WdResults
Transgenic mice overexpressing Wdr5 in osteoblasts (Col I-Wdr5)
display accelerated osteoblast differentiation (Gori et al., 2006). An
intriguing observation in these mice is an increase in the length of the
long bones, observed as early as E14.5, prior to vascular invasion.
Histologyof the growthplate of the transgenicmicedemonstrated that a
signiﬁcantexpansionof thehypertrophic chondrocyte layeraccounts for
the increased in the length of the long bones (Fig. 1A and Gori et al.,
2006), pointing to an important role of the Wdr5 transgene in
promoting chondrocyte differentiation. Because the size of the
hypertrophic chondrocyte layer is regulated by the rate at which
proliferative chondrocytes differentiate, BrdU incorporation assay
analyses were performed. As shown in Table 1, overexpression of
Wdr5 in the perichondrium resulted in a 62% increase in BrdU positive
cells in the proliferating chondrocyte layer (round and ﬂat chondro-
cytes). Pulse-chase experiments demonstrated a 103% increase in BrdU
positive cells in the hypertrophic layer 13 h post-BrdU injection. This
suggests that the Wdr5 transgene also accelerates the differentiation of
proliferating chondrocytes into hypertrophic chondrocytes. Since the
expression of the transgene is speciﬁcally restricted to the perichon-
drium and the expansion of the hypertrophic layer is not observed at
E13.5, prior to the appearance of osteoblasts in the bone collar (Gori et
al., 2006), these results support the hypothesis that Wdr5 over-
expression in the perichondrium causes the chondrocyte phenotype
observed in the Col I-Wdr5mice, by regulating the expression of factors
that, in a paracrine fashion, affect chondrocyte proliferation and
differentiation.
To determine if an ex vivo culture systemwould recapitulate the in
vivo phenotype, allowing the establishment of a model to permit
dissection of the molecular mechanism by which the Wdr5 transgene
results in a chondrocyte phenotype, metatarsals were isolated from
E15.5 wild-type and Col I-Wdr5 embryos. As shown in Fig. 1B, because
distal elements mature less rapidly than proximal bones, at E15.5 the
metatarsals of the Col I-Wdr5 embryos are undistinguishable from
those of their wild-type littermates (Fig. 1B). However, after 4 days
in culture, metatarsal elements of the Col I-Wdr5 embryos resemble
the phenotype seen in the humerus, including increased lengthcultures isolated fromwild-type (wt) and Col I-Wdr5 embryos. Type II collagen (Col II),
-) labeled or radiolabeled with 35S-UTP to a speciﬁc activity of at least 108 cpm/μg of
r5 embryos are shown.
Fig. 3. Wdr5 regulates FGF18 expression. (A) In situ hybridization analysis for FGF18.
Sections of humeri isolated from E14.5 wild-type (wt) and Col I-Wdr5 embryos are
shown. The FGF18 antisense riboprobe was radiolabeled with 35S-UTP to a speciﬁc
activity of at least 108 cpm/μg of template. Representative skeletal elements from at
least three wild-type and Col I-Wdr5 embryos are shown. Arrows point to FGF18
expression. (B) Quantitative real-time RT-PCR was performed on mRNA isolated from
E14.5 wild-type (wt) (open bars) and Col I-Wdr5 (black bars) humeri. Expression of
FGF18 mRNA was normalized to that of actin in the same sample. Values are expressed
as the relative expression of the normalized mRNAs levels of the Col I-Wdr5 humeri
versus that of wild-type (wt) humeri. Data shown are based on nine independent
mRNA isolations±S.E.M. ⁎pb0.05 by Student's t-test.
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characterize the chondrocyte phenotype of the humeri isolated from
E14.5 embryos and of the metatarsals cultured for 4 days, in situ
hybridization analyses were performed for type II collagen (Col II), a
speciﬁc marker of proliferating chondrocytes, type X collagen (Col X)
and osteopontin (OP), markers of hypertrophic chondrocytes. As
shown in Fig. 2, the cultured metatarsals recapitulated the in vivo
chondrocyte phenotype of the Col I-Wdr5 embryos, demonstrating a
marked expansion of the hypertrophic chondrocyte layer primarily
due to an increase in the domain of the more mature osteopontin
expressing hypertrophic chondrocytes. Similar to humeri isolated
from Col I-Wdr5 embryos, no differences were observed in the Col II
expression domain between metatarsal cultures isolated from wild-
type and Col I-Wdr5 embryos. These data demonstrate that, after
4 days in culture, metatarsal rudiments isolated from Col I-Wdr5 and
wild type embryos recapitulate the phenotype observed in vivo.
Therefore, this culture system provides a powerful tool to dissect the
mechanism by which Wdr5 expression in the perichondrium results
in the chondrocyte phenotype observed in the Col I-Wdr5 mice.
Several signaling pathways regulate chondrocyte proliferation
and differentiation. Notably, ablation of FGF18 leads to a phenotype
similar to that observed in the Col I-Wdr5 embryos: at E16.5 FGF18
null embryos demonstrate an expansion of the hypertrophic layer,
accompanied by an increase in chondrocyte proliferation in theproximal long bones (Liu et al., 2002). Thus, studies were under-
taken to determine whether expression of Wdr5 in the perichon-
drium impairs FGF18 expression. In situ hybridization analyses
demonstrate a decrease in FGF18 mRNA expression in perichondrial
cells of humeri isolated from Col I-Wdr5 embryos relative to humeri
isolated from their wild-type littermates (Fig. 3A). Quantitative real-
time PCR analyses conﬁrmed these data demonstrating a 30%
decrease in the level of the mRNA encoding FGF18 in humeri
isolated from E14.5 Col I-Wdr5 embryos relative to their wild type
littermates (Fig. 3B), thereby supporting the hypothesis that over-
expression of Wdr5 in the perichondrium promotes chondrocyte
differentiation by suppressing FGF18 expression. To explore the
hypothesis that the decrease in FGF18 mRNA levels in the
perichondrium of Col I-Wdr5 embryos maybe responsible for the
chondrocyte phenotype observed in these embryos, experiments
were carried out to investigate whether local delivery of FGF18 to
the perichondrium of cultured metatarsals isolated from Col I-Wdr5
embryos could prevent expansion of the hypertrophic chondrocyte
layer. As shown in Fig. 4A, implantation of FGF18 containing beads
in the bone collar of Col I-Wdr5 metatarsal cultures resulted in an
attenuation of the chondrocyte phenotype, evidenced by a decrease
in Col X and OP expression domains in metatarsal cultures
implanted with FGF18 coated beads relative to those implanted
with BSA coated beads. As expected, wild type metatarsal cultures
implanted with FGF18 coated beads displayed a smaller hyper-
trophic chondrocyte layer evidenced by decreased Col X and OP
mRNA expression domains, relative to wild-type metatarsals
implanted with BSA coated beads (Fig. 4B), demonstrating the
effectiveness of the experimental model and the bioactivity of the
FGF18. Thus, these experiments indicate that reversing the
decreased FGF18 expression in the perichondrium of transgenic
mice reverses the chondrocyte phenotype observed in these mice.
To further support this hypothesis, beads incubated with or without
the FGF inhibitor PD173074 (10 and 100 nM) (Skaper et al., 2000)
were implanted into the bone collar of cultured metatarsals isolated
from wild-type embryos and their Col I-Wdr5 littermates. As shown
in Fig. 5A, histological analyses demonstrate that blocking local FGF
signaling in the perichondrium of both wild type and Col I-Wdr5
metatarsals results in a dose-related expansion of the hypertrophic
chondrocyte layer. To conﬁrm these histological analyses, in situ
hybridization analyses were performed using Col X and OP. These
studies demonstrate that blocking FGF signaling in the perichon-
drium of wild-type metatarsal cultures recapitulates the expansion
of the hypertrophic chondrocyte layer seen in Col I-Wdr5 metatarsal
cultures characterized by an increase in the Col X and OP expression
domains (Fig. 5B). Inhibition of FGF signaling in Col I-Wdr5
metatarsal cultures further accentuates the phenotype of the
expanded hypertrophic chondrocyte layer (Fig. 5B) demonstrating
that Wdr5 overexpression in the perichondrium impairs, but does
not abolish FGF signaling. Similar results were obtained when beads
soaked in 10 nM of the inhibitor were used (Fig. 5A and data not
shown). Thus, these results support the hypothesis that over-
expression of Wdr5 in the perichondrium regulates FGF18 expres-
sion and are consistent with the hypothesis that impaired FGF18
expression is the cause of the accelerated chondrocyte differentia-
tion seen in Col I-Wdr5 mice.
FGF18 is induced by canonical Wnt signaling and Runx-2
(Kapadia et al., 2005; Reinhold and Naski, 2007). Because Wdr5 is
required for Runx-2 expression and for canonical Wnt signaling
(Zhu et al., 2008), suppression of FGF18 expression by the Wdr5
transgene suggests that Wdr5 overexpression in the perichondrium
must regulate the expression of factors that block induction of
FGF18 by Runx2 or Wnts. One such candidate, whose expression is
restricted to the perichondrium, is Twist-1 (Hinoi et al., 2006;
Reinhold et al., 2005). As shown in Fig. 6A, in situ hybridization
analyses demonstrate that the expression of Twist-1 is increased in
Fig. 4. Local delivery of FGF18 to the perichondrium attenuates the chondrocyte phenotype of the Col I-Wdr5 embryos. Heparin acrylic beads incubated with 1 mg/ml FGF18 or BSA
were implanted into the perichondrium of metatarsals isolated from E15.5 Col I-Wdr5 embryos (A) and their wild-type (wt) littermates (B). Metatarsals were then cultured for
4 days. Histological analysis and in situ hybridization analysis for Col X and OP were then performed. Arrows indicate heparin acrylic beads present in some sections. Representative
metatarsal cultures from at least six wild-type (wt) and Col I-Wdr5 embryos are shown.
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Col I-Wdr5 embryos relative to that of their wild type littermates. In
addition, quantitative real-time PCR showed a signiﬁcant increase in
Twist-1 mRNA in humeri isolated from E14.5 Col I-Wdr5 embryos
relative to that of their wild-type littermates (Fig. 6B). To determine
whether Wdr5 functionally interacts with Twist-1 in vivo, chromatin
immunoprecipitation (ChIP) analyses, using the osteoblastic cell line
MC3T3-E1, were performed. As shown in Fig. 6C, Wdr5 interacts
with the Twist-1 promoter region in the context of intact chromatin.
Thus, these data demonstrate that overexpression of Wdr5 leads to
increased expression of Twist-1 in the perichondrium. Since Wdr5
binds to the Twist-1 promoter in the context of intact chromatin,
this suggests that Wdr5 regulates Twist-1 expression. Since Twist-1
suppresses FGF18 expression (Hinoi et al., 2006), our ﬁndings
support the hypothesis that enhanced Twist-1 expression is
responsible for the changes in FGF18 mRNA levels observed in the
perichondrium of the Col I-Wdr5 mice. This decrease in FGF18 in
turn, promotes chondrocyte proliferation and differentiation during
endochondral bone formation.
Discussion
The formation of endochondral bones is a complex process that
requires intricate regulation of chondrocyte proliferation and differ-
entiation, as well osteoblast differentiation to ensure proper skeletal
development (Karsenty and Wagner, 2002; Kronenberg, 2003).
Several studies have demonstrated that local signals from the
proliferating, prehypertrophic and hypertrophic chondrocytes reg-
ulate chondrogenesis and osteogenesis during endochondral bone
development. In addition, signaling from the perichondrium has been
shown to regulate chondrocyte proliferation and differentiation,implicating coupling between chondrogenesis and osteogenesis
during endochondral bone formation (Chung et al., 2001; Di Nino et
al., 2001; Hinoi et al., 2006; Karp et al., 2000; Kronenberg, 2003; Long
and Linsenmayer, 1998).
We have found that overexpression of Wdr5 in the perichondrium
leads to an accelerated rate of chondrocyte maturation. Previous
studies have shown that, while endogenous Wdr5 is expressed in
proliferating chondrocytes, hypertrophic chondrocytes and osteo-
blasts, the expression of the Wdr5 transgene is restricted to
osteoblasts (Gori and Demay, 2004; Gori et al., 2006). Furthermore,
prior to the differentiation of precursor cells into type I collagen
expressing osteoblasts, a time when the Col I promoter driving the
transgene is not yet active in the perichondrium (Rossert et al., 1995),
Col I-Wdr5 embryos do not display the hypertrophic chondrocyte
phenotype (Gori et al., 2006). Thus, these histological and molecular
observations point to effects of Wdr5 on chondrocyte proliferation
and differentiation, mediated by signaling molecules expressed in the
developing bone, which regulate chondrocyte maturation in a
paracrine fashion.
Gain- and loss-of-function studies in mice have demonstrated that
FGFs and their receptors are crucial regulators of both intramembra-
nous and endochondral bone formation (Kronenberg, 2003; Marie,
2003; Ornitz, 2005). Among the FGFs, FGF18 expression is restricted to
the perichondrium and regulates chondrocyte proliferation and
differentiation as well as osteogenesis (Liu et al., 2007, 2002). Notably,
comparison of the growth plate of Col I-Wdr5 mice with that of FGF18
null mice at E16.5 shows a similar chondrocyte phenotype character-
ized by increased chondrocyte proliferation and expansion of the
hypertrophic layer (Liu et al., 2002), which suggest that Wdr5 might
regulate the expression of FGF18. Our results demonstrated decreased
FGF18 expression in Col I-Wdr5mice, suggesting thatWdr5 suppresses
Fig. 5. Blocking FGF signaling in the perichondrium recapitulates the Col I-Wdr5 phenotype in metatarsal cultures. (A) Afﬁgel blue beads incubated with 10 nM or 100 nM of FGF
inhibitor or DMSO were implanted into the perichondrium of metatarsals isolated from E15.5 wild-type (wt) and Col I-Wdr5 embryos. Metatarsals were then cultured for 4 days.
Histological analyses, using Toluidine Blue staining were then performed. (B) In situ hybridization analyses for Col X and OP were performed onmetatarsals isolated from E15.5 wild-
type (wt) and Col I-Wdr5 embryos implantedwith Afﬁgel blue beads incubated with 100 nM of FGF inhibitor or DMSO. Representative metatarsal cultures from at least six wild-type
(wt) and Col I-Wdr5 embryos are shown. Arrows point to beads present in some sections.
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differentiation. Consistent with the hypothesis that impaired FGF18
expression in the perichondrium of the Col I-Wdr5 mice may account
for the growth plate phenotype seen in these mice, our studies
demonstrated that local delivery of FGF18, via implantation of FGF18
coated beads in the perichondrium of metatarsal elements, attenuates
the phenotype of the Col I-Wdr5 metatarsals, whereas wild-type
metatarsal cultures implanted with beads soaked with an inhibitor of
FGF signaling recapitulate the Col I-Wdr5 chondrocyte phenotype.
The effects of FGF18 on chondrocyte proliferation and differentia-
tion vary depending on the stage of embryonic development
examined (Liu et al., 2007, 2002). Notably, studies in the FGF18 null
mice demonstrate a smaller hypertrophic chondrocyte layer, accom-
panied by decreased chondrocyte proliferation and delayed vascular
invasion in the paw at E14.5 and E15.5 which is the converse of the
phenotype observed in the Col I-Wdr5 mice (Liu et al., 2007).
However, at later developmental stages (E16.5) the FGF18 null mice
demonstrate an expansion of the hypertrophic chondrocyte layeraccompanied by an increase in chondrocyte proliferation in the
proximal long bones (Liu et al., 2002). Thus, the growth plate
phenotype of the FGF18 null mice at this stage of endochondral bone
formation is identical to that of the Col I-Wdr5 mice. The ﬁndings that
the Col I promoter drives LacZ expression in the humerus between
E13.5 and E14.5 (andmuch later in the distal elements) (Rossert et al.,
1995), might explain the difference observed at early stages of
endochondral bone formation, between the Col I-Wdr5 mice and the
FGF18 null mice. In the latter, FGF signaling is impaired from the time
of fertilization, whereas in the former, FGF signaling is unaffected for
the ﬁrst two weeks of embryogenesis.
Since FGF18 is induced by canonical Wnt signaling (Kapadia et al.,
2005; Reinhold andNaski, 2007), which is enhanced in the osteoblasts
of Col I-Wdr5 mice and by Runx-2 whose expression is regulated by
Wdr5 (Gori et al., 2006; Zhu et al., 2008), the observation that FGF18
expression was decreased in Col I-Wdr5 mice seemed somehow
paradoxical. This raised the question as to whether overexpression of
Wdr5 indirectly suppresses FGF18 expression by enhancing the
Fig. 6.Wdr5 regulates Twist-1 expression. (A) In situ hybridization analysis for Twist-1. Sections of humeri isolated from E14.5 wild-type (wt) and Col I-Wdr5 embryos are shown.
Twist-1 antisense riboprobe was radiolabeled with 35S-UTP to a speciﬁc activity of at least 108 cpm/μg of template. Representative humeri from at least three wild-type (wt) and Col
I-Wdr5 embryos are shown. Arrows point to the expression of Twist-1. (B) Quantitative real-time RT-PCR was performed on mRNA isolated from E14.5 wild-type (wt) (open bars)
and Col I-Wdr5 (black bars) humeri. Expression of Twist mRNAwas normalized to that of actin in the same sample. Values are expressed as the relative expression of the normalized
mRNAs levels of the humeri from Col I-Wdr5 embryos versus that of wild-type (wt) humeri. Data shown are based on nine independent mRNA isolations±S.E.M. ⁎pb0.05 by
Student's t-test. (C) Quantitative ChIP analyses demonstrating a speciﬁc interaction of Wdr5 with the Twist-1 promoter. Values are shown as enrichment of the promoter sequences
normalized for coding region sequences versus that obtained for input samples. Data shown are representative of that obtained with three independent experiments±S.E.M.
⁎pb0.05 by Student's t-test for ChIP samples versus input samples.
42 F. Gori et al. / Developmental Biology 329 (2009) 36–43expression of factors that block the induction of FGF18 by Runx-2 or by
the canonical Wnt signaling pathway.
Our studies demonstrate that Wdr5 associates with the Twist-1
promoter and that Twist-1 expression is increased in Col I-Wdr5
mice. Twist-1, a basic helix–loop–helix transcription factor
expressed in perichondrial cells but not in chondrocytes, interacts
with the Runx-2 DNA binding domain, thereby inhibiting its activity
(Bialek et al., 2004). Interestingly, overexpression of Twist-1 in
osteoblasts under the control of the mouse α(1) I collagen promoter
leads to a hypertrophic chondrocyte phenotype analogous to that
seen in the Col I-Wdr5 mice (Hinoi et al., 2006). In these mice,
Twist-1 inhibits Runx-2 activity leading to suppression of FGF18
expression, thereby accelerating chondrocyte maturation (Hinoi et
al., 2006). Since Wdr5 is essential for histone H3 lysine 4 (H3K4)
trimethylation (Dou et al., 2005; Wysocka et al., 2003, 2005), one of
the histone modiﬁcations associated with transcriptional activation
of genes, our chromatin immunoprecipitation data suggest that
Wdr5 regulates chromatin modiﬁcations at the Twist-1 promoter
leading to activation of Twist-1 expression. This hypothesis is
supported by our ﬁndings that Twist-1 expression is signiﬁcantly
increased in Col I-Wdr5 mice. Thus, we propose that by enhancing
the expression of Twist-1 in the perichondrium, Wdr5 overexpres-
sion results in decreased FGF18 expression thereby promoting
chondrocyte differentiation. The increase in Twist-1 expression in
Col I-Wdr5 mice may also explain the ﬁnding that, despite the
decrease in FGF18 expression, Col I-Wdr5 mice display enhanced
osteoblast differentiation. In fact, based on the delayed osteoblast
differentiation observed in mice with a hypomorphic Twist-1 allele
(Hinoi et al., 2006), it is possible that the enhanced expression in
Twist-1, observed in the Col I-Wdr5 mice, contributes to enhanced
osteoblastogenesis.
Our data do not exclude the possibility that other signaling
pathways involved in chondrocyte proliferation and differentiation
may contribute to the chondrocyte phenotype of the Col I-Wdr5
transgenic mice. Although further in vivo functional studies,
currently underway, are needed to determine at what extent
Wdr5 is required to regulate osteoblastogenesis and chondroctye
maturation in vivo, the current studies provide evidence for a
mechanism by which overexpression of Wdr5 in the perichondrium
induces the expression of Twist-1 leading to a decrease in FGF18
expression. This results in accelerated chondrocyte proliferation and
differentiation and reinforces the concept that signals from theperichondrium play an important role in the regulation of
chondrocyte proliferation and differentiation during endochondral
bone development.
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